Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Torti

Showing results (91-100 of 263) with videos related to

Pageof 27
Sort By:
European Journal of Medical Research|August 18, 2023
Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohortShannan N Rich, Paola Nasta, Eugenia Quiros-Roldan, et al.
Journal of Medical Virology|July 20, 2004
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patientsCarlo Torti, Eugenia Quiros-Roldan, Laura Monno, et al.
Multiple Sclerosis and Related Disorders|December 23, 2017
Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatmentStefania Barone, Sara Scannapieco, Carlo Torti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen)Annalisa Saracino, Laura Monno, Sergio Locaputo, et al.
HIV Clinical Trials|December 26, 2002
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal studyAndrea Patroni, Carlo Torti, Lina Tomasoni, et al.
Health Science Reports|May 10, 2021
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 levelCarlo Torti, Vincenzo Scaglione, Bruno Mario Cesana, et al.
International Journal of Antimicrobial Agents|November 19, 2023
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practiceArturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
Frontiers in Public Health|January 22, 2024
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care?Enrico Maria Trecarichi, Vincenzo Olivadese, Chiara Davoli, et al.
Journal of Medical Virology|December 5, 2015
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with menRenzo Scaggiante, Samantha Andreis, Monica Basso, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the "Magna Graecia" University Unit of Infectious Diseases: A Didascalic ReviewFerdinando Carmelo Pio Lionello, Salvatore Rotundo, Gabriele Bruno, et al.
Pageof 27

Showing results (91-100 of 263) with videos related to

Sort By:
Pageof 27
European Journal of Medical Research|August 18, 2023
Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohortShannan N Rich, Paola Nasta, Eugenia Quiros-Roldan, et al.
Journal of Medical Virology|July 20, 2004
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patientsCarlo Torti, Eugenia Quiros-Roldan, Laura Monno, et al.
Multiple Sclerosis and Related Disorders|December 23, 2017
Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatmentStefania Barone, Sara Scannapieco, Carlo Torti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen)Annalisa Saracino, Laura Monno, Sergio Locaputo, et al.
HIV Clinical Trials|December 26, 2002
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal studyAndrea Patroni, Carlo Torti, Lina Tomasoni, et al.
Health Science Reports|May 10, 2021
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 levelCarlo Torti, Vincenzo Scaglione, Bruno Mario Cesana, et al.
International Journal of Antimicrobial Agents|November 19, 2023
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practiceArturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
Frontiers in Public Health|January 22, 2024
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care?Enrico Maria Trecarichi, Vincenzo Olivadese, Chiara Davoli, et al.
Journal of Medical Virology|December 5, 2015
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with menRenzo Scaggiante, Samantha Andreis, Monica Basso, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the "Magna Graecia" University Unit of Infectious Diseases: A Didascalic ReviewFerdinando Carmelo Pio Lionello, Salvatore Rotundo, Gabriele Bruno, et al.
Pageof 27